Skip to main content
. 2015 Mar 24;10(3):e0121185. doi: 10.1371/journal.pone.0121185

Fig 2. Encapsulation efficiency and in vivo drug release profiles.

Fig 2

(A) Encapsulation efficiency of TPCA-1 by a solvent-evaporation process is around 80%. (B) Choroid/RPE/retina TPCA-1 release profile at 1, 7, 14, and 21 days post retrobulbar administration of TPCA-1/PLGA (0.8 mg TPCA-1/10 mg PLGA in 100 μL PBS) microparticles. Data expressed as mean±SD, n = 3 (individual experimental mice).